The Oncology Institute, Inc. (TOI)
| Market Cap | 15.87M |
| Revenue (ttm) | 378.93M |
| Net Income (ttm) | -57.47M |
| Shares Out | 75.56M |
| EPS (ttm) | -0.77 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 586,610 |
| Open | 0.229 |
| Previous Close | 0.207 |
| Day's Range | 0.193 - 0.229 |
| 52-Week Range | 0.125 - 2.500 |
| Beta | 0.44 |
| Analysts | Strong Buy |
| Price Target | 2.50 (+1,089.91%) |
| Earnings Date | Nov 13, 2024 |
About TOI
The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplan... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to one analyst, the rating for TOI stock is "Strong Buy" and the 12-month stock price forecast is $2.5.
News
Florida Blue enhances cancer care for thousands of members
New program aims to improve patient outcomes, experience, and quality of life by streamlining access to affordable and high-quality oncology care New program aims to improve patient outcomes, experien...
Grapevine Saves The Oncology Institute Millions On Healthcare Supplies
Proof that Digital Transformation and Smarter Supply Chains Can Massively Cut Costs Proof that Digital Transformation and Smarter Supply Chains Can Massively Cut Costs
The Oncology Institute, Inc. (TOI) Q3 2024 Earnings Call Transcript
The Oncology Institute, Inc. (NASDAQ:TOI) Q3 2024 Earnings Conference Call November 13, 2024 5:00 PM ET Company Participants Mark Hueppelsheuser - General Counsel Daniel Virnich - CEO Rob Carter - CF...
The Oncology Institute Announces Third Quarter 2024 Earnings Release Date and Conference Call
CERRITOS, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, LLC (“TOI”) (NASDAQ: TOI) one of the largest value-based oncology groups in the United States, today announced that the comp...
The Oncology Institute Joins Lantern's Cancer Care Network of Excellence
CERRITOS, Calif., Oct. 23, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the nation, has joined Lantern's leading specialty car...
The Oncology Institute of Hope & Innovation Launches Oregon Market
Anchor value-based payor partnership leads to opening of locations in Portland and Salem Anchor value-based payor partnership leads to opening of locations in Portland and Salem
The Oncology Institute, Inc. (TOI) Q2 2024 Earnings Call Transcript
The Oncology Institute, Inc. (NASDAQ:TOI) Q2 2024 Earnings Conference Call August 13, 2024 5:00 PM ET Company Participants Mark Hueppelsheuser – General Counsel Dan Virnich – Chief Executive Officer ...
The Oncology Institute to Participate at Upcoming Investor Conferences
CERRITOS, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology practices in the country, today announced that Dr. Daniel Virnich...
The Oncology Institute Executives to Participate in Multiple Panel Presentations at APG 2024 Spring Conference
CERRITOS, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- Today, the Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) have announced their executives' participation in multiple panel presentations a...
The Oncology Institute, Inc. (TOI) Q1 2024 Earnings Call Transcript
The Oncology Institute, Inc. (NASDAQ:TOI) Q1 2024 Earnings Conference Call May 14, 2024 5:00 PM ET Company Participants Dan Virnich - Chief Executive Officer Mihir Shah - Chief Financial Officer Conf...
The Oncology Institute Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Guidance
CERRITOS, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, t...
The Oncology Institute and Healthly Forge Strategic Alliance to Elevate Cancer Care Access to Healthly Patients Across Southern California
CERRITOS, Calif., April 04, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) and Healthly, a rapidly growing healthcare company with over 180 primary care physici...
The Oncology Institute, Inc. (TOI) Q4 2023 Earnings Call Transcript
The Oncology Institute, Inc. (TOI) Q4 2023 Earnings Call Transcript
The Oncology Institute Reports Fourth Quarter and Full Year 2023 Financial Results and Guidance for 2024
CERRITOS, Calif., March 27, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States,...
MaxHealth & The Oncology Institute Expand Value-Based Care Partnership
TOI announces clinical and financial accountability for MaxHealth Oncology Care in 5 Florida Counties TOI announces clinical and financial accountability for MaxHealth Oncology Care in 5 Florida Count...
The Oncology Institute Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Conference Call
CERRITOS, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, LLC (“TOI”) (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that the co...
Carrum Health and The Oncology Institute Partner on Breast Cancer Treatment Model
Value-based care program offers Las Vegas patients access to high quality cancer care while reducing costs for employers Value-based care program offers Las Vegas patients access to high quality cance...
The Oncology Institute Expands its Specialty Medication Business by Opening Pharmacy Operations in California
CERRITOS, Calif, Dec. 04, 2023 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (TOI) announced today that it has started operations of its first pharmacy in California after receiving approval from t...
The Oncology Institute, Inc. (TOI) Q3 2023 Earnings Call Transcript
The Oncology Institute, Inc. (NASDAQ:TOI) Q3 2023 Earnings Conference Call November 8, 2023 5:00 PM ET Company Participants Mark Hueppelsheuser - General Counsel Dan Virnich - Chief Executive Officer...
The Oncology Institute Announces Third Quarter 2023 Earnings Release Date and Conference Call
CERRITOS, Calif., Oct. 18, 2023 (GLOBE NEWSWIRE) -- The Oncology Institute, LLC (“TOI”) (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that the com...
The Oncology Institute Names Jeremy Castle as Chief Operations Officer
CERRITOS, Calif., Oct. 11, 2023 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) has announced the appointment of Jeremy Castle, MBA, as Chief Operations Officer, effective September 5, ...
The Oncology Institute Executive Leaders to Present at the 2023 Association for Value-Based Cancer Care (AVBCC) Summit
CERRITOS, Calif., Sept. 26, 2023 (GLOBE NEWSWIRE) -- The Oncology Institute of Hope and Innovation (TOI) is excited to announce that multiple executives including CEO, Dr. Daniel Virnich, CMO, Dr. Yal...
The Oncology Institute Regains Compliance with Nasdaq Listing Requirements
CERRITOS, California, Sept. 18, 2023 (GLOBE NEWSWIRE) -- The Oncology Institute (NASDAQ: TOI) (the “Company”), one of the largest value-based community oncology groups in the United States, today anno...
The Oncology Institute, Inc. (TOI) Q2 2023 Earnings Call Transcript
The Oncology Institute, Inc. (NASDAQ:TOI) Q2 2023 Earnings Conference Call August 8, 2023 5:00 PM ET Company Participants Mark Hueppelsheuser - General Counsel Dan Virnich - Chief Executive Officer M...
Ambience Healthcare and The Oncology Institute (TOI) Partner to Create a Best-in-Class Oncology Experience for Patients and Clinicians, Leveraging Breakthrough Generative AI Technology
CERRITOS, Calif., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Ambience Healthcare, a market leader in generative AI technology for clinical documentation, workflows, and patient experience, and The Oncology Ins...